Evidence map›Paper›PMID 35480675›Full record

ArticleRSC advances2021

Ductile keratin films from deep eutectic solvent-fractionated feathers.

Emmi-Maria Nuutinen, Tommi Virtanen, Raija Lantto, Mika Vähä-Nissi, Anna-Stiina Jääskeläinen

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Emmi-Maria NuutinenSustainable products and materials, VTT, Technical Research Centre of Finland Tietotie 2 FI-02044 Espoo Finland emmi.nuutinen@vtt.fi +358406817126.ORCID https://orcid.org/0000-0002-9131-0914
Tommi VirtanenSustainable products and materials, VTT, Technical Research Centre of Finland Tietotie 2 FI-02044 Espoo Finland emmi.nuutinen@vtt.fi +358406817126.
Raija LanttoSustainable products and materials, VTT, Technical Research Centre of Finland Tietotie 2 FI-02044 Espoo Finland emmi.nuutinen@vtt.fi +358406817126.
Mika Vähä-NissiSustainable products and materials, VTT, Technical Research Centre of Finland Tietotie 2 FI-02044 Espoo Finland emmi.nuutinen@vtt.fi +358406817126.
Anna-Stiina JääskeläinenSustainable products and materials, VTT, Technical Research Centre of Finland Tietotie 2 FI-02044 Espoo Finland emmi.nuutinen@vtt.fi +358406817126.
Tieto (Finland) · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Feathers, an industrial by-product, are a valuable source of keratin that could be used, for example, in the preparation of films for biomedical and packaging applications. However, the utilisation of feather keratin requires scalable processes to convert feathers into a feasible keratin stream. This paper shows how deep eutectic solvent (DES) fractionated feathers could be converted into strong films. In the DES fractionation process, two keratin fractions with different molecular weights were obtained. The films made of the high molecular weight keratin fraction had better mechanical properties and stability against moisture than the films made of the low molecular weight keratin fraction. The strength properties were further improved by cross-linking the keratin with diglycidyl ether enabling the formation of a uniform keratin network, whereas glutaraldehyde did not show a clear cross-linking effect. These keratin films could be used, for example, in food packaging or medical applications such as wound care.

Identifiers

PMID35480675
PMCPMC9037859
OpenAlexW3193670309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.